Literature DB >> 16711020

Expression of vascular endothelial growth factor and cyclooxygenase-2 in laryngeal squamous cell carcinoma and its significance.

Guangli Chen1, Yingpeng Liu, Jianting Wang, Linghui Luo, Pei Chen, Juan Ding, Shusheng Gong.   

Abstract

In order to study the expressions of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) in human laryngeal squamous cell carcinoma (LSCC) and its significance, the expression of VEGF mRNA and COX-2 mRNA in 62 cases of LSCC and 54 adjacent noncancerous laryngeal tissues and 9 normal human laryngeal mucous tissues was detected by using techniques of semi-quantitative RT-PCR. It was found that the expression level of VEGF and COX-2 mRNA was significantly increased in LSCC as compared with that in the normal human laryngeal mucous tissues (both P < 0.01), and the expression level of VEGF and COX-2 mRNA were significantly increased in stage Ill + IV tissues of LSCC as compared with the stage I + II tissues of LSCC (P < 0.01). There was a high positive correlation between VEGF and COX-2 expression in LSCC (r = 0.756, P < 0.01). These data raise the possibility that VEGF and COX-2 may play key roles in the growth, invasion and metastasis of LSCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711020     DOI: 10.1007/bf02828052

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.

Authors:  Y Eli; F Przedecki; G Levin; N Kariv; A Raz
Journal:  Biochem Pharmacol       Date:  2001-03-01       Impact factor: 5.858

Review 2.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Authors:  J Holash; S J Wiegand; G D Yancopoulos
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

3.  Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.

Authors:  Terence-C Tang; Ronnie-T Poon; Cecilia-P Lau; Dan Xie; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

4.  Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer.

Authors:  Takeyoshi Yamauchi; Masahiko Watanabe; Tetsuro Kubota; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Yasuo Kabeshima; Kyoko Yorozuya; Kentaro Yamamoto; Makio Mukai; Masaki Kitajima
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

5.  Anti-angiogenic cues from vascular basement membrane collagen.

Authors:  P C Colorado; A Torre; G Kamphaus; Y Maeshima; H Hopfer; K Takahashi; R Volk; E D Zamborsky; S Herman; P K Sarkar; M B Ericksen; M Dhanabal; M Simons; M Post; D W Kufe; R R Weichselbaum; V P Sukhatme; R Kalluri
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

6.  Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.

Authors:  Ang Yuan; Chong-Jen Yu; Chia-Tung Shun; Kwen-Tay Luh; Sow-Hsong Kuo; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Int J Cancer       Date:  2005-07-01       Impact factor: 7.396

7.  Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer.

Authors:  G M Boxer; E Tsiompanou; T Levine; R Watson; R H J Begent
Journal:  Tumour Biol       Date:  2005-02-28

8.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

  8 in total
  1 in total

1.  CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

Authors:  Anke Schlüter; Patrick Weller; Oliver Kanaan; Ivonne Nel; Lukas Heusgen; Benedikt Höing; Pia Haßkamp; Sebastian Zander; Magis Mandapathil; Nina Dominas; Judith Arnolds; Boris A Stuck; Stephan Lang; Agnes Bankfalvi; Sven Brandau
Journal:  BMC Cancer       Date:  2018-03-09       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.